HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoichi Nishiya Selected Research

draflazine

1/2014The anti-overactive bladder activity of KW-7158 is mediated by blocking equilibrative nucleoside transporter-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoichi Nishiya Research Topics

Disease

2Overactive Urinary Bladder (Overactive Bladder)
01/2014 - 11/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Neoplasms (Cancer)
01/2020
1Malignant Mesothelioma
01/2020
1Spinal Cord Injuries (Spinal Cord Injury)
01/2014

Drug/Important Bio-Agent (IBA)

2KW 7158IBA
01/2014 - 11/2011
1Phosphotransferases (Kinase)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Neurofibromin 2 (Merlin)IBA
01/2020
1Dipyridamole (Persantine)FDA LinkGeneric
01/2014
1draflazineIBA
01/2014
1NucleosidesIBA
01/2014
1Pharmaceutical PreparationsIBA
11/2011